Immediate Impact
2 by Nobel laureates 34 from Science/Nature 81 standout
Citing Papers
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
2019 Standout
A view on drug resistance in cancer
2019 StandoutNature
Works of Joan Lucca being referenced
Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer
2007
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer.
2001
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Joan Lucca | 736 | 671 | 193 | 25 | 998 | |
| A. Y. Chang | 488 | 723 | 230 | 39 | 1.2k | |
| Valerie K. Israel | 895 | 861 | 267 | 17 | 1.2k | |
| Gianfranco Buccheri | 570 | 545 | 235 | 50 | 974 | |
| Qi Liu | 472 | 381 | 220 | 42 | 1.0k | |
| Borys Hrinczenko | 363 | 715 | 155 | 28 | 1.1k | |
| Robert F. Marschke | 273 | 576 | 196 | 39 | 857 | |
| M. Veslemes | 540 | 766 | 346 | 39 | 1.0k | |
| G.P.M. ten Velde | 604 | 443 | 145 | 31 | 901 | |
| Diane Savarese | 516 | 567 | 271 | 24 | 1.2k | |
| J. Wendall Goodwin | 326 | 513 | 185 | 34 | 984 |
All Works
Loading papers...